Published in J Trauma on August 01, 2004
Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol (2002) 3.33
Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-beta signaling. Nat Med (2005) 2.06
The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane. Kidney Int (2004) 1.91
Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus. J Rheumatol (2009) 1.84
Interplay between IFN-gamma and IL-6 signaling governs neutrophil trafficking and apoptosis during acute inflammation. J Clin Invest (2003) 1.69
IL-6 regulates neutrophil trafficking during acute inflammation via STAT3. J Immunol (2008) 1.69
Soluble IL-6 receptor governs IL-6 activity in experimental arthritis: blockade of arthritis severity by soluble glycoprotein 130. J Immunol (2003) 1.68
IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation. Proc Natl Acad Sci U S A (2005) 1.66
The natural course of peritoneal membrane biology during peritoneal dialysis. Kidney Int Suppl (2003) 1.58
The pathophysiology of the peritoneal membrane. J Am Soc Nephrol (2010) 1.47
Human neutrophil clearance of bacterial pathogens triggers anti-microbial γδ T cell responses in early infection. PLoS Pathog (2011) 1.46
Interleukin-6 regulation of transforming growth factor (TGF)-beta receptor compartmentalization and turnover enhances TGF-beta1 signaling. J Biol Chem (2005) 1.45
12/15-Lipoxygenase regulates the inflammatory response to bacterial products in vivo. J Immunol (2008) 1.38
Loss of CD4+ T cell IL-6R expression during inflammation underlines a role for IL-6 trans signaling in the local maintenance of Th17 cells. J Immunol (2010) 1.36
A rapid crosstalk of human gammadelta T cells and monocytes drives the acute inflammation in bacterial infections. PLoS Pathog (2009) 1.35
Therapeutic targeting of IL-6 trans signaling counteracts STAT3 control of experimental inflammatory arthritis. J Immunol (2009) 1.35
Soluble TLR2 reduces inflammation without compromising bacterial clearance by disrupting TLR2 triggering. J Immunol (2009) 1.22
Independent effects of systemic and peritoneal inflammation on peritoneal dialysis survival. J Am Soc Nephrol (2013) 1.18
Phosphatidylethanolamine-esterified eicosanoids in the mouse: tissue localization and inflammation-dependent formation in Th-2 disease. J Biol Chem (2009) 1.18
Differential regulation of neutrophil-activating chemokines by IL-6 and its soluble receptor isoforms. J Immunol (2004) 1.14
Pathogen-specific local immune fingerprints diagnose bacterial infection in peritoneal dialysis patients. J Am Soc Nephrol (2013) 1.09
Functional characterization of a soluble gp130 isoform and its therapeutic capacity in an experimental model of inflammatory arthritis. Arthritis Rheum (2006) 1.07
Esterified eicosanoids are acutely generated by 5-lipoxygenase in primary human neutrophils and in human and murine infection. Blood (2010) 1.02
Effects of conventional and new peritoneal dialysis fluids on leukocyte recruitment in the rat peritoneal membrane. J Am Soc Nephrol (2003) 1.01
Enhanced neutrophil migratory activity following major blunt trauma. Injury (2005) 1.01
Naive and activated T cells display differential responsiveness to TL1A that affects Th17 generation, maintenance, and proliferation. FASEB J (2010) 1.01
TLR activation enhances C5a-induced pro-inflammatory responses by negatively modulating the second C5a receptor, C5L2. Eur J Immunol (2011) 1.00
Interferon-gamma protects against the development of structural damage in experimental arthritis by regulating polymorphonuclear neutrophil influx into diseased joints. Arthritis Rheum (2007) 0.98
Secretion of oncostatin M by infiltrating neutrophils: regulation of IL-6 and chemokine expression in human mesothelial cells. J Immunol (2002) 0.97
Glucose degradation products (GDP) retard remesothelialization independently of D-glucose concentration. Kidney Int (2003) 0.97
Peritoneal dialysis: changes to the structure of the peritoneal membrane and potential for biocompatible solutions. Kidney Int Suppl (2003) 0.96
Sp1 and Sp3 mediate constitutive transcription of the human hyaluronan synthase 2 gene. J Biol Chem (2006) 0.96
Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Crit Care Med (2002) 0.95
Functional effector memory T cells enrich the peritoneal cavity of patients treated with peritoneal dialysis. J Am Soc Nephrol (2009) 0.94
Glucose-mediated induction of TGF-beta 1 and MCP-1 in mesothelial cells in vitro is osmolality and polyol pathway dependent. Kidney Int (2003) 0.93
Identification and analysis of the promoter region of the human hyaluronan synthase 2 gene. J Biol Chem (2004) 0.92
Intraperitoneal IL-6 signaling in incident patients treated with icodextrin and glucose bicarbonate/lactate-based peritoneal dialysis solutions. Perit Dial Int (2012) 0.91
Interferon-gamma inhibits interleukin-1beta-induced matrix metalloproteinase production by synovial fibroblasts and protects articular cartilage in early arthritis. Arthritis Res Ther (2010) 0.88
Can artifact mimic the pathology of the peritoneal mesothelium? Perit Dial Int (2003) 0.88
Human peritoneal mesothelial cells respond to bacterial ligands through a specific subset of Toll-like receptors. Nephrol Dial Transplant (2011) 0.87
Viral IL-6 blocks neutrophil infiltration during acute inflammation. J Immunol (2005) 0.86
Clinical indices of in vivo biocompatibility: the role of ex vivo cell function studies and effluent markers in peritoneal dialysis patients. Kidney Int Suppl (2003) 0.86
Morphological and functional changes in the dialysed peritoneal cavity: impact of more biocompatible solutions. Nephrol Dial Transplant (2002) 0.86
Oncostatin M receptor-beta signaling limits monocytic cell recruitment in acute inflammation. J Immunol (2008) 0.85
The human hyaluronan synthase genes: genomic structures, proximal promoters and polymorphic microsatellite markers. Int J Biochem Cell Biol (2003) 0.84
Dialysate interleukin-6 predicts increasing peritoneal solute transport rate in incident peritoneal dialysis patients. BMC Nephrol (2014) 0.84
Peritoneal membrane transport: driving under the influence. Perit Dial Int (2006) 0.84
How can genetic advances impact on experimental models of encapsulating peritoneal sclerosis? Perit Dial Int (2008) 0.82
Nitric oxide synthase isoforms play distinct roles during acute peritonitis. Nephrol Dial Transplant (2009) 0.82
Piece by piece: solving the puzzle of peritoneal fibrosis. Perit Dial Int (2008) 0.81
Neutrophil priming for elastase release in adult blunt trauma patients. J Trauma (2006) 0.80
Targeting the TLR co-receptor CD14 with TLR2-derived peptides modulates immune responses to pathogens. Sci Transl Med (2013) 0.79
Inhibition of nitric oxide synthase reverses permeability changes in a mouse model of acute peritonitis. Perit Dial Int (2005) 0.79
Receptor-interacting protein-2 deficiency delays macrophage migration and increases intracellular infection during peritoneal dialysis-associated peritonitis. Am J Nephrol (2008) 0.78
Proteomics and peritoneal dialysis: early days but clear potential. Nephrol Dial Transplant (2010) 0.78
Continuous dialysis with bicarbonate/lactate-buffered peritoneal dialysis fluids results in a long-term improvement in ex vivo peritoneal macrophage function. J Am Soc Nephrol (2002) 0.78
Switching on EMT in the peritoneal membrane: considering the evidence. Nephrol Dial Transplant (2010) 0.77
Suppression of pro-inflammatory T-cell responses by human mesothelial cells. Nephrol Dial Transplant (2013) 0.76
Altering peritoneal membrane function: removing the GAG? Nephrol Dial Transplant (2009) 0.76
Peritoneal fibrosis is mouse strain dependent. Nephrol Dial Transplant (2012) 0.76
Now you see them, now you don't. Perit Dial Int (2004) 0.75
Encapsulating peritoneal sclerosis: time to act. Perit Dial Int (2006) 0.75
Neutrophil activation and renal scarring. Kidney Int (2005) 0.75
Peritoneal infection and inflammation. Mediators Inflamm (2012) 0.75
The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactate-buffered peritoneal dialysis fluid. Kidney Int Suppl (2003) 0.75
What are renal defensins defending? Nephron Exp Nephrol (2003) 0.75